Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2024 event, please get in touch at info@hansonwade.com

Welcome to the Inaugural Gene Therapy Potency Assay Summit

Identify, Characterize and Measure Potency to Ensure Safety, Efficacy & Consistency of your Gene Therapy

The Inaugural Gene Therapy Potency Summit (Ran August 29-31) dedicated itself to providing attendees with the tools to identify, characterize and measure potency, enabling them to take tactical insights back to their teams. The content focused on the “sweet spot” of drug development where potency is most critical - pre-clinical development through to commercialization.

This is the only industry-led event dedicated to covering all challenges associated with potency for gene therapy drug developers specifically. We united with 60+ analytical, bioassay, Quality Control, regulatory and CMC experts to bring together content that gave actionable insights by combining both strategic and technical content.

2023 World Class Speaker Faculty:

Previously Attending Companies Include:

Top Testimonial

"Very informative and intellectually stimulating with engaged participants and high-quality speakers."

Senior Scientist - Analytical Development, Novartis Gene Therapies

Our 2023 Partners:

CYTOO_jpeg
Bio-Techne (PRNewsFoto/Bio-Techne Corporation,B-MoGen)